In mammals, the JAK/STAT pathway appears to be the main signaling mechanism for a wide array of cytokines and growth factors, and JAK inhibitors are efficient in IBD therapies [82,83]. The gene discussed is SOAT1; the disease is inflammatory bowel disease.